Arise Bio- Care Profile
Key Indicators
- Authorised Capital ₹ 0.40 M
as on 29-07-2024
- Paid Up Capital ₹ 0.40 M
as on 29-07-2024
- Company Age 23 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 24.46%
(FY 2023)
- Profit -81.29%
(FY 2023)
- Ebitda 39.58%
(FY 2023)
- Net Worth 1.13%
(FY 2023)
- Total Assets 3.42%
(FY 2023)
About Arise Bio- Care
The Corporate was formerly known as Arise Biocare Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.40 M and a paid-up capital of Rs 0.40 M, as per Ministry of Corporate Affairs (MCA) records.
Darshan Vaishnav, Niraj Shah, and Naresh Shah serve as directors at the Company.
- CIN/LLPIN
U51397GJ2001PTC039185
- Company No.
039185
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jan 2001
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Arise Bio- Care Private Limited offer?
Arise Bio- Care Private Limited offers a wide range of products and services, including Bath Soaps, Beauty Soap, Pharmaceutical Medicine, Medicated Soap, Pimple Care Soap.
Who are the key members and board of directors at Arise Bio- Care?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Darshan Vaishnav  | Director | 19-Jan-2001 | Current |
| Niraj Shah | Director | 14-Apr-2011 | Current |
| Naresh Shah | Director | 25-Apr-2011 | Current |
Financial Performance of Arise Bio- Care.
Arise Bio- Care Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 24.46% increase. The company also saw a substantial fall in profitability, with a 81.29% decrease in profit. The company's net worth moved up by a moderate rise of 1.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arise Bio- Care?
In 2023, Arise Bio- Care had a promoter holding of 5.00% and a public holding of 95.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nimeru Healthcare And Cosmetics Private LimitedActive 19 years 10 monthsNiraj Shah and Naresh Shah are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Arise Bio- Care?
Unlock and access historical data on people associated with Arise Bio- Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arise Bio- Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arise Bio- Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
